From a "Grexit" to the closure of banks, here are six myths about the Greek crisis, says Nicholas Economides, an NYU professor and adviser to Greece.» Read More
The billionaire investor believes the Fed won't be in any hurry to increase rates—in part because of the softer U.S. economy.
Crowded "long" trades unwinding
China's banks are taking over the world, or at least pushing their U.S. counterparts out of the leadership role, analyst Dick Bove says.
Don't forget to look beyond China and India for investing in Asian growth, according to pros at the Milken Institute Global Conference.
Tracking simple electricity usage is a helpful predictor in discerning broader market movements, according to a research team at Notre Dame.
Very low jobless claims may be a sign that March's low employment report will be revised upward.
Small chance Fed will hike in June.
Investors should be wary of bubbles in several crowded trades in today's market, according to large investment managers at Milken.
The really weak economic numbers—particularly the disappointing GDP—implies two trades could be coming a bit unwound.
The surge in M&A isn't likely to subside anytime soon, according to two senior bankers from Goldman Sachs and Citigoup.
The first-quarter gross domestic product report put several dents in popular Wall Street economic narratives, none of which bode well for growth.
The market responded modestly to a weak first quarter GDP report, and traders are now waiting to see how the Federal Reserve reacts.
Silicon Valley may still be chasing the unicorns of tech, but at least one big Wall Street investor is thinking more like a vulture.
Big money managers have a warning for investors using unconstrained bond funds, liquid alternatives and other innovative products.
A funny thing has been happening to financials: while earnings have been stellar, their stocks have stunk.
Bill Ackman and Carl Icahn have a friend in Ken Griffin.
Major private equity managers, including several billionaires, gave their best investment idea at the Milken conference.
Three former U.S. Treasury Secretaries agree: The U.S. has plenty of problems, but it's still in a dominant global position.
It might soon be time to hand your money to the robots.
Biotech, which has been a market leader all year, is weak, with both the market-cap weighted IBB and equal weighted XBI down roughly 4 percent each.